Search results
Erowid is a non-profit educational & harm-reduction resource with 60 thousand pages of online information about psychoactive drugs, plants, chemicals, and technologies including entheogens, psychedelics, new psychoactive substances, research chemicals, stimulants, depressants and pharmaceuticals.
- Chemicals
Extensive information about psychoactive chemicals and drugs...
- All Sections
[ Search What's New] [ RSS Feed] Wed Oct 2, 2024 # New...
- Experiences
The index into Erowid's collection of more than 45,000...
- Freedom
As nightfall does not come at once, neither does oppression....
- Culture
Information about influential or inspirational people in the...
- 2023 September Drive
Erowid received over 1150 donations in September, one of our...
- Tech
Information about technologies, devices, hardware and...
- By Substance
The full list of substances and categories covered by...
- Chemicals
10 paź 2024 · Discover the most relevant papers, trials, events, companies, and people in our extensive collection of over 5,000 entries and 100,000 data points. Our interconnected databases allow you to uncover valuable insights and connections in psychedelic research.
The index into Erowid's collection of more than 45,000 personal reports describing first-hand experiences with psychoactive plants and drugs.
Through several proposed mechanisms of actions, from neurological to psychological, psychedelic medicines have been shown to have powerful pain reducing effects across a wide variety of conditions. Data continues to mount in research trials across the globe. Search the database below for pain conditions and keep scrolling for the Autoimmune and ...
30 lip 2024 · What are psychedelic substances? Why are they currently being researched in the medical field? Are psychedelics already available for treatment in Europe? These are some of the issues addressed in a new set of EUDA Frequently Asked Questions (FAQs): therapeutic use of psychedelic substances released today.
Mapping Drug Development in Psychedelics. This overview seeks to map out drug discovery & development activity in psychedelics. Drugs currently undergoing clinical trials are presented first, while drugs that are at the discovery or preclinical stage are catalogued in the latter half of this page.
MAPS is your trusted source for evidence-based information about psychedelic substances and integrated treatments. Charting a course for the future of psychedelics Since 1986. History. Since 1986, MAPS has worked tirelessly to build and share the blueprint for ending psychedelic prohibition.
